Arabic Arabic English English French French German German
dark

Avisa Diagnostics to Participate at Upcoming Investor Events – July 09, 2021

Avisa Diagnostics Inc., a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of virulent bacterial lung infections, announced that the Company will participate in several virtual investor events in July. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Effect of yoga and physiotherapy on pulmonary functions in children with Duchenne muscular dystrophy.

Next Post

BeiGene Announces the Approval in China of KYPROLIS® (Carfilzomib) for Injection for Adult Patients with Relapsed or Refractory Multiple Myeloma

Related Posts
Total
0
Share